Actively Recruiting
Clinical Outcomes of Use of Olaparib in Castration Resistant Prostate Cancer
Led by Santa Chiara Hospital · Updated on 2025-02-11
3000
Participants Needed
2
Research Sites
208 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This is an observational, retrospective/prospective, multicenter study designed to define, overall survival, clinical outcomes and predictive/prognostic factors of a consecutive population of mCRPC patients treated with olaparib in clinical practice.
CONDITIONS
Official Title
Clinical Outcomes of Use of Olaparib in Castration Resistant Prostate Cancer
Who Can Participate
Eligibility Criteria
You may qualify if you...
- BRCA mutant metastatic castration-resistant prostate cancer patients treated with olaparib in clinical practice
You will not qualify if you...
- Patients receiving olaparib treatment as part of a clinical trial
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 2 locations
1
Sabrina Rossetti
Naples, Italy
Actively Recruiting
2
Orazio Caffo
Trento, Italy
Actively Recruiting
Research Team
O
Orazio Caffo, MD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here